European Invesmtent Bank (EIB). (1/9/23). "Press Release: Belgium – ExeVir Lands European Venture Debt Financing to Develop Novel Nanobody COVID-19 Therapy". |
2023-01-09 |
Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. |
2023-01-09 |
Synaffix B.V.. (1/5/23). "Press Release: Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs". Amsterdam. |
2023-01-05 |
Synaffix B.V.. (1/4/23). "Press Release: Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program". Amsterdam, San Francisco, CA, et al.. |
2023-01-04 |
European Invesmtent Bank (EIB). (12/23/22). "Press Release: Sweden – EIB Lends €20 Million to Biotech Company for Development of Biopharmaceuticals to Treat Cancer and Inflammatory Diseases". |
2022-12-23 |
InflaRx N.V.. (12/21/22). "Press Release: InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19". Jena. |
2022-12-21 |
European Invesmtent Bank (EIB). (12/20/22). "Press Release: Germany – EIB Provides €20 Million in Financing to Innovative Diagnostics Developer Numares". |
2022-12-20 |
Corbion N.V.. (12/13/22). "Press Release: Corbion Appoints Jennifer Lindsey as Chief Marketing and Digital Officer". |
2022-12-13 |
Ion Beam Applications S.A. (IBA). (12/8/22). "Press Release: IBA Wins 10 Proton Therapy System Contract in Spain". Louvain-la-Neuve. |
2022-12-08 |
i&i Biotech Fund. (11/30/22). "Press Release: Experienced Businessmen Join Forces with Excellent Science, Invest € 2 Million in the Fund at the IOCB". Prague. |
2022-11-30 |
BioWin. (11/29/22). "Press Release: BioWin Expands Its »Growth & Financing« Member Service by Appointing Two Industry Experts". Gosselies. |
2022-11-29 |
Uniqure N.V.. (11/22/22). "Press Release: Uniqure Announces FDA Approval of First Gene Therapy for Adults with Hemophilia B". Research Triangle Park, NC. |
2022-11-22 |
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". |
2022-11-18 |
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". |
2022-11-17 |
Azenta, Inc.. (11/8/22). "Press Release: Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg". Chelmsford, MA. |
2022-11-08 |
VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam. |
2022-11-08 |
BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. |
2022-11-08 |
Novadip Biosciences S.A.. (11/3/22). "Press Release: Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million". Mont-Saint-Guibert. |
2022-11-03 |
Centogene N.V.. (11/3/22). "Press Release: Centogene Launches Rare and Neurodegenerative Disease Biodata Network". Cambridge, MA, Rostock & Berlin. |
2022-11-03 |
Enzyre B.V.. (11/2/22). "Press Release: Enzyre Closes Series A Financing Round of EUR 12M to Advance Pioneering Diagnostic Technology Platform for Hemophilia Patients". Nijmegen. |
2022-11-02 |
Orionis Biosciences. (10/19/22). "Press Release: Orionis Biosciences Secures $55 Million Financing to Support Advancement into Clinic". Boston, MA & Ghent. |
2022-10-19 |
Univercells S.A.. (10/19/22). "Press Release: Univercells Raises € 44 Million in First Close of Its Series D". Brussels. |
2022-10-19 |
Immatics N.V.. (10/10/22). "Press Release: Immatics Reports Interim Clinical Data Update on ACTengine IMA203 TCR-T Monotherapy Targeting PRAME". Houston, TX & Tübingen. |
2022-10-10 |
Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen. |
2022-10-10 |
NLC Ventures Netherlands B.V.. (10/5/22). "Press Release: Crainio, an NLC Venture, Sets Out to Revolutionise the Measurement of Intracranial Pressure (ICP) by Developing a Non-invasive Measuring Device". |
2022-10-05 |
Newton Biocapital. (9/29/22). "Press Release: Philippe De Backer Joins Newton Biocapital as a Senior Partner". Brussels. |
2022-09-29 |
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". |
2022-09-27 |
Precirix N.V.. (9/12/22). "Press Release: Precirix Enters into Collaboration with Eckert & Ziegler for the Development of Its 68Ga-based Compounds". Brussels & Berlin. |
2022-09-12 |
Immatics N.V.. (9/10/22). "Press Release: Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022". Houston, TX & Tübingen. |
2022-09-10 |
NLC Ventures Netherlands B.V.. (9/8/22). "Press Release: AIDO, an NLC venture, Has Made It Its Mission to Bring more Control to Physicians Performing Endoscopic Procedures and Lower the Threshold to Expand Complex Interventions". |
2022-09-08 |
Pleco Therapeutics B.V.. (9/6/22). "Press Release: Pleco Therapeutics Announces Final Close of Its Series A Financing Raising €17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU". Nijmegen. |
2022-09-06 |
The Protein Brewery B.V.. (9/1/22). "Press Release: The Protein Brewery Appoints Sue Garfitt as CEO". Breda. |
2022-09-01 |
Centogene N.V.. (9/1/22). "Press Release: Centogene to Present at Upcoming Investor & Partnering Conferences in September". Cambridge, MA, Rostock & Berlin. |
2022-09-01 |
Gilde Healthcare Partners. (8/29/22). "Press Release: Gilde Healthcare Acquires Sanquin Reagents". Utrecht. |
2022-08-29 |
Immatics N.V.. (8/23/22). "Press Release: Immatics Announces First Cancer Patient Treated with Second-generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME". Houston, TX & Tübingen. |
2022-08-23 |
eTheRNA Immunotherapeutics N.V.. (8/23/22). "Press Release: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA". Niel. |
2022-08-23 |
Immatics N.V.. (8/9/22). "Press Release: Immatics Announces Second Quarter 2022 Financial Results and Business Update". Tübingen & Houston, TX. |
2022-08-09 |
Argenx SE. (8/8/22). "Press Release: Argenx Announces European Commission Approval of Vyvgart (efgartigimod alfa-fcab) for the Treatment of Generalized Myasthenia Gravis". |
2022-08-08 |
MDxHealth S.A.. (8/2/22). "Press Release: MDxHealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results". Irvine, CA & Herstal. |
2022-08-02 |
S-Biomedic N.V.. (8/2/22). "Press Release: S-Biomedic Welcomes Pascal Yvon to Lead Its B2B Commercial Activities". Beerse. |
2022-08-02 |
NLC Ventures Netherlands B.V.. (8/2/22). "Press Release: Haermonics Series A Funding Offers Pure™ Promise for Future Heart Surgery Patients". Eindhoven. |
2022-08-02 |
Precirix N.V.. (7/26/22). "Press Release: Precirix and Eckert & Ziegler Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225". Brussels & Berlin. |
2022-07-26 |
Pleco Therapeutics B.V.. (7/26/22). "Press Release: Pleco Therapeutics Announces Expansion with the Incorporation of a U.S. Subsidiary and the Appointment of Michael Stalhamer as President". Nijmegen & New Jersey. |
2022-07-26 |
NewAmsterdam Pharma Holding B.V.. (7/25/22). "Press Release: NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Oral Therapies for Cardiometabolic Disea |
2022-07-25 |
Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden. |
2022-07-20 |
Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. |
2022-07-18 |
Agomab Therapeutics N.V.. (7/13/22). "Press Release: Agomab Raises Additional $40.5 Million through Series B Extension Bringing Total Amount to $114 Million". Ghent. |
2022-07-13 |
NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence. |
2022-06-28 |
Centogene N.V.. (6/27/22). "Press Release: Centogene Announces Appointment of Miguel Coego Rios as Chief Financial Officer". Cambridge, MA, Rostock & Berlin. |
2022-06-27 |
Verve Capital Partners AG (Verve Ventures). (6/24/22). "Press Release: Verve Ventures Launches Investment Fund to Support Portfolio Companies". |
2022-06-24 |
Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen. |
2022-06-21 |
Galapagos N.V.. (6/21/22). "Press Release: Galapagos to Acquire CellPoint and AboundBio to Accelerate Access to Next-generation Cell Therapies". Mechelen, Leiden & Pittsburgh, PA. |
2022-06-21 |
Atai Life Sciences N.V.. (6/17/22). "Press Release: Stephen Bardin to Join Atai Life Sciences as CFO Designate". New York, NY & Berlin. |
2022-06-17 |
Gimv. (6/15/22). "Press Release: Gimv Strengthens Its Position in Life Sciences Venture Capital with the Creation of a New Dedicated Platform". Antwerp. |
2022-06-15 |
CimCure. (6/21/22). "Press Release: Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures". |
2022-06-10 |
Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. |
2022-06-09 |
Ziphius Vaccines N.V.. (6/9/22). "Press Release: Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics". |
2022-06-09 |
Immatics N.V.. (6/7/22). "Press Release: Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer". Tübingen, Houston, T |
2022-06-07 |
DSM N.V.. (6/2/22). "Press Release: DSM and Firmenich to Merge, Becoming the Leading Creation and Innovation Partner in Nutrition, Beauty and Well-being [NOT FOR RELEASE WHERE VIOLATION OF LAW]". Vienna. |
2022-06-02 |
Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY. |
2022-06-02 |
Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg. |
2022-05-31 |
NLC Ventures Netherlands B.V.. (5/23/22). "Press Release: Allergios Closes Their Latest Round of Seed Financing". |
2022-05-23 |
Synexa Life Sciences B.V.. (5/19/22). "Press Release: Synexa Life Sciences Acquires Finnish CRO Syrinx Bioanalytics to Expand Bioanalysis Capabilities". Leiden. |
2022-05-19 |
FlandersBio. (5/18/22). "Press Release: Flanders.Bio Appoints CEO and COO in Newly Created Role". |
2022-05-18 |
Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. |
2022-05-18 |
Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. |
2022-05-17 |
Bone Therapeutics S.A.. (5/12/22). "Press Release: Bone Therapeutics Enters into Exclusive Reverse Merger Discussions with Medsenic". Mont-Saint-Guibert. |
2022-05-12 |
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Acquires Majority Stake in Enzymes Provider BLIRT S.A.". Hilden & Germantown, MD. |
2022-05-11 |
Qiagen N.V.. (5/11/22). "Press Release: Qiagen Proposes Expansion of Supervisory Board. Dr. Eva Pisa Proposed as a New Member to the Supervisory Board". Venlo. |
2022-05-11 |
European Spatial Biology Center (ESBC). (5/4/22). "Press Release: The European Spatial Biology Center (ESBC). State-of-the-Art Spatial Biology Services Enabled at Scale in Leuven". |
2022-05-04 |
Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel. |
2022-05-03 |
Bone Therapeutics S.A.. (4/29/22). "Press Release: Bone Therapeutics Announces 2021 Full Year Results". Mont-Saint-Guibert. |
2022-04-29 |
ProteoNic B.V.. (4/26/22). "Press Release: ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies". Leiden. |
2022-04-26 |
Stentit B.V.. (4/25/22). "Press Release: MedTech Company Stentit Raises €1.8 Million in Seed Round". Eindhoven. |
2022-04-25 |
VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". |
2022-04-20 |
NLC Ventures Netherlands B.V.. (4/20/22). "Press Release: Charles River Laboratories and NLC Collaborate". |
2022-04-20 |
Monkeys not Donkeys. (4/13/22). "Press Release: Quality by Design (QbD) Acquires Marketing & Communication Agency ‘Monkeys not Donkeys’ to Strengthen Its Services within the Life Science Industry". Wilrijk & Ghent. |
2022-04-13 |
Bone Therapeutics S.A.. (4/12/22). "Press Release: Bone Therapeutics Secures EUR 5 Million Financing [Not for US, AU, CA, et al.]". Mont-Saint-Guibert. |
2022-04-12 |
Forbion Capital Partners. (3/31/22). "Press Release: Forbion Appoints Both Dr Ton Logtenberg and Dr Michael Hayden as Venture Partners". Naarden. |
2022-03-31 |
Avantium N.V.. (3/31/22). "Press Release: Avantium Reaches Financial Close for its FDCA Flagship Plant". Amsterdam. |
2022-03-31 |
V-Bio Ventures. (3/31/22). "Press Release: V-Bio Ventures Raises EUR 110 Million for its Second Fund and Expands Team". Ghent. |
2022-03-31 |
miDiagnostics N.V.. (3/30/22). "Press Release: miDiagnostics Welcomes Nicolas De Clercq as Its New Chief Financial Officer". Leuven. |
2022-03-30 |
Argenx SE. (3/29/22). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. |
2022-03-29 |
Bone Therapeutics S.A.. (3/29/22). "Press Release: Bone Therapeutics to Strategically Focus on Lead Cell Therapy Product ALLOB". Mont-Saint-Guibert. |
2022-03-29 |
European Invesmtent Bank (EIB). (3/24/22). "Press Release: Austria – EIB Supports Innovacell’s Innovative Cell Therapy for Treating Incontinence". |
2022-03-24 |
Argenx SE. (3/23/22). "Press Release: Argenx Raises $700 Million in Gross Proceeds in a Global Offering". Breda. |
2022-03-23 |
Immatics N.V.. (3/23/22). "Press Release: Immatics Announces Full Year 2021 Financial Results and Corporate Update". Tübingen & Houston, TX. |
2022-03-23 |
Qbic. (3/17/22). "Press Release: Qbic Establishes Third Fund. Qbic Announces First Close of New Fund at € 49 Million to Invest in Spin-offs from World-class Knowledge Partners". St-Denijs-Westrem. |
2022-03-17 |
Precirix N.V.. (3/16/22). "Press Release: Precirix Raises EUR 80m in Series B to Advance Its Pipeline of Precision Radiopharmaceuticals". Brussels. |
2022-03-16 |
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. |
2022-03-16 |
Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. |
2022-03-14 |
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. |
2022-03-10 |
European Invesmtent Bank (EIB). (3/7/22). "Press Release: Italy – EIB Provides €7.5 Million Loan for Research and Development of Diadem’s AlzoSure Predict Blood Test for Alzheimer’s disease". |
2022-03-07 |
ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. |
2022-03-01 |
Ncardia Services B.V.. (2/24/22). "Press Release: Ncardia Appoints Andy Holt as Chief Commercial Officer". Leiden. |
2022-02-24 |
ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. |
2022-02-23 |
TargED Biopharmaceuticals B.V.. (2/22/22). "Press Release: TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients". Utrecht. |
2022-02-22 |
Newton Biocapital. (2/15/22). "Press Release: Newton Biocapital Launches a New Fund with Initial Capital Commitments of EUR 50 Million and Target Size of EUR 150 Million". Brussels. |
2022-02-15 |
Life Sciences Partners (LSP). (2/11/22). "Press Release: LSP Closes EUR 1 Billion Flagship Fund LSP 7 to Invest in Life Sciences Companies". Amsterdam. |
2022-02-11 |
ProQR Therapeutics N.V.. (2/11/22). "Press Release: ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10". Leiden & Cambridge, MA. |
2022-02-11 |